Zenas BioPharma, Inc. (ZBIO)
NASDAQ·Healthcare·Biotechnology
$28.48
+2.51%
Mkt Cap $1.85B
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (9 analysts)
$43.50
Range $32.00 – $55.00
Implied Upside
+52.7%
Consensus $43.50 vs current $28.48
NASDAQ·Healthcare·Biotechnology
$28.48
+2.51%
Mkt Cap $1.85B
Buy
7
Hold
2
Sell
0
Price Target (9 analysts)
$43.50
Range $32.00 – $55.00
+52.7%
Consensus $43.50 vs current $28.48